Abstract
Lymph nodes are among the most commonly sampled organs. The common causes of lymphadenopathy include metastatic cancers, reactive hyperplasia due to various stimuli, infections, and lymphomas. Fine-needle aspiration (FNA) of a lymph node is a safe, relatively simple, and effective modality in the evaluation of lymphadenopathy. Diff-Quik stain offers rapid provisional assessment and can guide the further workup for the patient. Diff-Quik stain also provides information on cytoplasm and extracellular matrix. Papanicolaou stain reveals nuclear details. Cell block allows histologic sections and immunohistochemical studies. FNA can provide samples for ancillary studies such as flow cytometric analysis and cytogenetic and molecular studies. Ancillary studies are complementary to morphology and can further improve the diagnostic accuracy. This chapter summarizes the cytological features of various lymph node lesions and defines the roles of ancillary studies in the diagnosis and prognosis.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Schafernak KT, Kluskens LF, Ariga R, Reddy VB, Gattuso P. Fine-needle aspiration of superficial and deeply seated lymph nodes on patients with and without a history of malignancy: review of 439 cases. Diagn Cytopathol. 2003;29:315–9.
Nasuti JF, Mehrotra R, Gupta PK. Diagnostic value of fine-needle aspiration in supraclavicular lymphadenopathy: a study of 106 patients and review of literature. Diagn Cytopathol. 2001;25:351–5.
Glant MD. Cytopathology of lymph nodes in nonspecific reactive hyperplasia. Prognostication and differential diagnoses. Am J Clin Pathol. 1997;108(4 Suppl 1):S31–55.
O’Dowd GJ, Frable WJ, Behm FG. Fine needle aspiration cytology of benign lymph node hyperplasias. Diagnostic significance of lymphohistiocytic aggregates. Acta Cytol. 1985;29:554–8.
Pilotti S, Di Palma S, Alasio L, Bartoli C, Rilke F. Diagnostic assessment of enlarged superficial lymph nodes by fine needle aspiration. Acta Cytol. 1993;37:853–66.
Schwarz R, Chan NH, MacFarlane JK. Fine needle aspiration cytology in the evaluation of head and neck masses. Am J Surg. 1990;159:482–5.
Zhou J, Li F, Meng L, Hao F, Liu X, Zhao C, et al. Fine needle aspiration cytology for lymph nodes: a three-year study. Br J Biomed Sci. 2016;73:28–31.
Ramzy I, Rone R, Schultenover SJ, Buhaug J. Lymph node aspiration biopsy. Diagnostic reliability and limitations—an analysis of 350 cases. Diagn Cytopathol. 1985;1:39–45.
Hyun SJ, Kim EK, Yoon JH, Moon HJ, Kim MJ. Adding MRI to ultrasound and ultrasound-guided fine-needle aspiration reduces the false-negative rate of axillary lymph node metastasis diagnosis in breast cancer patients. Clin Radiol. 2015;70:716–22.
Basler GC, Fader DJ, Yahanda A, Sondak VK, Johnson TM. The utility of fine needle aspiration in the diagnosis of melanoma metastatic to lymph nodes. J Am Acad Dermatol. 1997;36:403–8.
Wang H, Liang J, Yong WH, Sullivan P. Metastatic pituitary carcinoma to cervical lymph node: diagnosis by fine needle aspiration and review of the literature. Acta Cytol. 2017;61:242–6.
Stewart CJ, Duncan JA, Farquharson M, Richmond J. Fine needle aspiration cytology diagnosis of malignant lymphoma and reactive lymphoid hyperplasia. J Clin Pathol. 1998;51:197–203.
Das DK. Value and limitations of fine-needle aspiration cytology in diagnosis and classification of lymphomas: a review. Diagn Cytopathol. 1999;21:240–9.
Katz RL. Cytologic diagnosis of leukemia and lymphoma. Values and limitations. Clin Lab Med. 1991;11:469–99.
Katz RL, Caraway NP. FNA lymphoproliferative diseases: myths and legends. Diagn Cytopathol. 1995;12:99–100.
Sneige N. Diagnosis of lymphoma and reactive lymphoid hyperplasia by immunocytochemical analysis of fine-needle aspiration biopsy. Diagn Cytopathol. 1990;6:39–43.
Paull G, Mosunjac M. Fine-needle aspiration biopsy and intraoperative cytologic smear findings in a case of benign mesothelial-cell inclusions involving a lymph node: case report and review of the literature. Diagn Cytopathol. 2003;29:163–6.
Gallan AJ, Antic T. Benign müllerian glandular inclusions in men undergoing pelvic lymph node dissection. Hum Pathol. 2016;57:136–9.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
Stein H, Delsol G, Pileri SA, Poppema S, Jaffe ES. Classical Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 326–9.
The Non-Hodgkin’s Lymphoma Classification Project. A clinical evaluation of the International Lymphoma Study Group classification of non-Hodgkin’s lymphoma. Blood. 1997;89:3909–18.
Dal Bo M, Bulian P, Bomben R, Zucchetto A, Rossi FM, Pozzo F, et al. CD49d prevails over the novel recurrent mutations as independent prognosticator of overall survival in chronic lymphocytic leukemia. Leukemia. 2016;30:2011–8.
Gooden CE, Jones P, Bates R, Shallenberger WM, Surti U, Swerdlow SH, Roth CG. CD49d shows superior performance characteristics for flow cytometric prognostic testing in chronic lymphocytic leukemia/small lymphocytic lymphoma. Cytometry B Clin Cytom. 2018;94(1):129–35. https://doi.org/10.1002/cyto.b.21384.
Strati P, Parikh SA, Chaffee KG, Achenbach SJ, Slager SL, Call TG, et al. CD49d associates with nodal presentation and subsequent development of lymphadenopathy in patients with chronic lymphocytic leukaemia. Br J Haematol. 2017;178:99–105.
Zelenetz AD, Wierda WG, Abramson JS, Advani RH, Andreadis CB, Bartlett N, et al. Non-Hodgkin’s lymphomas, version 3.2012. J Natl Compr Canc Netw. 2012;10:1487–98.
Chen R, Sanchez J, Rosen ST. Clinical management updates in mantle cell lymphoma. Oncology (Williston Park). 2016;30:353–60.
Hashmi AA, Hussain ZF, Faridi N, Khurshid A. Distribution of Ki67 proliferative indices among WHO subtypes of non-Hodgkin’s lymphoma: association with other clinical parameters. Asian Pac J Cancer Prev. 2014;15:8759–63.
Katzenberger T, Petzoldt C, Höller S, Mäder U, Kalla J, Adam P, et al. The Ki67 proliferation index is a quantitative indicator of clinical risk in mantle cell lymphoma. Blood. 2006;107:3407.
Hsi ED, Jung SH, Lai R, Johnson JL, Cook JR, Jones D, et al. Ki67 and PIM1 expression predict outcome in mantle cell lymphoma treated with high dose therapy, stem cell transplantation and rituximab: a Cancer and Leukemia Group B 59909 correlative science study. Leuk Lymphoma. 2008;49:2081–90.
Anderson JR, Armitage JO, Weisenburger DD. Epidemiology of the non-Hodgkin’s lymphomas: distributions of the major subtypes differ by geographic locations. Non-Hodgkin’s Lymphoma Classification Project. Ann Oncol. 1998;9:717–20.
Koch K, Hoster E, Ziepert M, Unterhalt M, Ott G, Rosenwald A, et al. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol. 2016;27:1323–9.
Mercadal S, Pomares H, Sancho JM, Climent F, García O, Encuentra M, et al. Clinico-biological features, treatment and survival of 457 patients with histological Grades 3A and 1-2 follicular lymphoma mostly treated with immunochemotherapy. Br J Haematol. 2016;172:470–3.
Horn H, Ziepert M, Becher C, Barth TF, Bernd HW, Feller AC, et al. German High-Grade Non-Hodgkin Lymphoma Study Group. MYC status in concert with BCL2 and BCL6 expression predicts outcome in diffuse large B-cell lymphoma. Blood. 2013;121:2253–63.
Klopčič U, Lavrenčak J, Gašljević G, Bračko M, Pohar-Marinšek Ž, Kloboves-Prevodnik V. Grading of follicular lymphoma in cytological samples. Cytopathology. 2016;27:390–7.
Hans CP, Weisenburger DD, Greiner TC, Gascoyne RD, Delabie J, Ott G, et al. Confirmation of the molecular classification of diffuse large B-cell lymphoma by immunohistochemistry using a tissue microarray. Blood. 2004;103:275–82.
Horn H, Schmelter C, Leich E, Salaverria I, Katzenberger T, Ott MM, et al. Follicular lymphoma grade 3B is a distinct neoplasm according to cytogenetic and immunohistochemical profiles. Haematologica. 2011;96:1327–34.
Snuderl M, Kolman OK, Chen YB, Hsu JJ, Ackerman AM, Dal Cin P, et al. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma. Am J Surg Pathol. 2010;34:327–40.
McKenna RW, Kyle RA, Kuehl WM, Grogan TM, Harris NL, Coupland RW. Plasma cell neoplasms. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 200–13.
Cazals-Hatem D, Lepage E, Brice P, Ferrant A, d’Agay MF, Baumelou E, et al. Primary mediastinal large B-cell lymphoma. A clinicopathologic study of 141 cases compared with 916 nonmediastinal large B-cell lymphomas, a GELA (“Groupe d’Etude des Lymphomes de l’Adulte”) study. Am J Surg Pathol. 1996;20:877–88.
Barth TF, Leithäuser F, Joos S, Bentz M, Möller P. Mediastinal (thymic) large B-cell lymphoma: where do we stand? Lancet Oncol. 2002;3:229–34.
Poppema S, Delsol G, Pileri SA, Stein H. Nodular lymphocyte predominant Hodgkin lymphoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 323–5.
Delsol G. [The 2008 WHO lymphoma classification]. Ann Pathol. 2008;28 Spec No 1:S20–4.
Pileri SA, Orazi A, Falini B. Myeloid sarcoma. In: Swerdlow SH, Campo E, Harris NL, Jaffe ES, Pileri SA, Stein H, et al., editors. WHO classification of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC; 2008. p. 140–1.
Almagro UA, Choi H, Rouse TM. Hemangioma in a lymph node. Arch Pathol Lab Med. 1985;109:576–8.
Reich RF, Moss S, Freedman PD. Intranodal hemangioma of the oral soft tissues: a case report of a rare entity with review of the literature. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2000;90:71–3.
Kasznica J, Sideli RV, Collins MH. Lymph node hemangioma. Arch Pathol Lab Med. 1989;113:804–7.
Wakely PE Jr, Frable WJ, Kneisl JS. Aspiration cytopathology of epithelioid angiosarcoma. Cancer. 2000;90:245–51.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2018 Springer International Publishing AG, part of Springer Nature
About this chapter
Cite this chapter
Samedi, V.G., Zhang, QY. (2018). Lymph Node Cytology. In: Jing, X., Siddiqui, M., Li, Q. (eds) Atlas of Non-Gynecologic Cytology . Atlas of Anatomic Pathology. Springer, Cham. https://doi.org/10.1007/978-3-319-89674-8_11
Download citation
DOI: https://doi.org/10.1007/978-3-319-89674-8_11
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-89673-1
Online ISBN: 978-3-319-89674-8
eBook Packages: MedicineMedicine (R0)